Crossref
Ebola outbreak puts nimble treatment trial designs to the test
Science · 28.05.2026 · 392 (6801) · 910-911
DOI: 10.1126/science.aej2010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science, erschienen am 28.05.2026. Verfasst von Kai Kupferschmidt. Hauptthemen laut MEDLINE: Antiviral Agents, Disease Outbreaks, Hemorrhagic Fever, Ebola, Therapies, Investigational.
Abstract (Originalsprache)
Updated strategies for studying antivirals and antibodies will face logistical challenges on the ground
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Antiviral AgentsDisease OutbreaksHemorrhagic Fever, EbolaTherapies, InvestigationalHumansAntibodies, ViralEbolavirusAdenosine MonophosphateAlanine
Substanzen
Antibodies, ViralAntiviral AgentsremdesivirAdenosine MonophosphateAlanine
Zitieren
APA
Kupferschmidt, K. (2026). Ebola outbreak puts nimble treatment trial designs to the test. Science, 392(6801), 910-911. https://doi.org/10.1126/science.aej2010
Vancouver
Kupferschmidt K. Ebola outbreak puts nimble treatment trial designs to the test. Science. 2026;392(6801):910-911. doi:10.1126/science.aej2010
BibTeX
@article{Kupferschmidt2026,
author = {Kupferschmidt, Kai},
title = {Ebola outbreak puts nimble treatment trial designs to the test},
journal = {Science},
year = {2026},
volume = {392},
number = {6801},
pages = {910--911},
doi = {10.1126/science.aej2010}
}
EUVIMED